Aperçu Produits fournitures pour les tests médicaux

Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

Name: Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection
Brand: Sichuan Hundred Medcal Technology Co., Ltd.
SKU: /
Availability: InStock

Tous les produits

Appareil médical domestique
(42)

Fournitures de protection médicale
(13)

Dispositif dentaire médical
(23)

Consommables pour chirurgie
(35)

Analyseur médical
(12)

fournitures pour les tests médicaux
(19)

Équipement de diagnostic médical
(41)

Équipement de sauvetage d'urgence
(13)

Équipement de thérapie respiratoire
(5)

matériel de surveillance médicale
(10)

Produits médicaux de santé
(25)

Approvisionnements enroulés de soin
(6)

Équipement de stérilisation médicale
(1)

Équipement médical de réadaptation
(14)

Équipement hyperbare
(2)

Certificat

Je suis en ligne une discussion en ligne

Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

Image Grand : Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

Détails sur le produit:

Lieu d'origine:	Chine
Nom de marque:	HDRMEDICO
Certification:	CE
Numéro de modèle:	/

Conditions de paiement et expédition:

Quantité de commande min:	500 pièces
Prix:	Négociable
Détails d'emballage:	Carton
Délai de livraison:	10-15 jours
Conditions de paiement:	L / C, T / T, Westen Union, Money Gram, PayPal / VTB
Capacité d'approvisionnement:	100000PC/mois

Contact Causez Maintenant

Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

description de

Nom du produit:	Cassette de test rapide du virus Chikungunya	Matériel:	Plastique
Catégorie de produit:	Diagnostic in vitro	Méthode:	Méthode de l'or colloïdal
Durée de conservation:	Deux ans	Fonction:	Détection
Mettre en évidence:	Chikungunya virus rapid test cassette , Colloidal gold antibody detection test , IgM IgG rapid test cassette

Chikungunya Virus Rapid Test Cassette

This in vitro diagnostic device utilizes immunochromatographic (colloidal gold) technology for the rapid, qualitative detection of anti-Chikungunya virus IgM and IgG antibodies in human serum, plasma, or whole blood samples.

Technology & Methodology

The test operates on a lateral flow immunoassay principle. Recombinant Chikungunya virus antigens are immobilized on the nitrocellulose membrane at distinct test lines (T-IgM and T-IgG). When a sample is applied, anti-CHIKV antibodies bind to the antigen-colloidal gold conjugate, forming visible colored lines at the respective test lines.

Intended Use & Clinical Applications

This rapid test serves as an important aid in the presumptive diagnosis of recent or past Chikungunya virus infection, particularly useful in:

Outbreak Settings: Rapid screening of febrile patients in areas with active CHIKV transmission
Differential Diagnosis: Distinguishing Chikungunya fever from other clinically similar arboviral diseases such as dengue or Zika virus infection
Case Management: Supporting clinical decision-making for patients with acute onset of high fever and severe joint pain

Key Features & Advantages

Rapid Results: Visual results typically within 10-20 minutes for quick clinical triage
Simultaneous Detection: Detects both IgM (recent infection) and IgG (later stage or past infection) antibodies from a single sample
Ease of Use: Simple procedure requiring minimal training and no specialized laboratory equipment
High Clinical Utility: Positive IgM result with compatible symptoms strongly suggests acute Chikungunya infection

Result Interpretation

Result	Interpretation
IgM Positive	Suggests recent or current Chikungunya virus infection
IgG Positive	Indicates later-stage or past infection/exposure
Both IgM & IgG Positive	Common during the convalescent phase
Negative	No detectable levels of anti-CHIKV antibodies (does not completely rule out early infection)
Invalid	Control line (C) fails to appear - test must be repeated

Important Notes

This is a screening test. All reactive results, especially in low-prevalence areas, should be confirmed by more specific serological methods (ELISA, PRNT) or molecular tests (RT-PCR) in a reference laboratory. Test performance may vary depending on sample collection timing relative to symptom onset. Clinical history and epidemiological context are essential for accurate diagnosis.

Produit Tag:

Personne à contacter: Mr. Terry

Téléphone: 15008220675

Autres Produits